News

Energesis Awarded Phase II SBIR Grant for the Development of Novel Brown Adipose Recruiters

Sept, 2017 - The company has been awarded a new phase II small business grant to continue its development of novel compounds with the ability to recruit new brown fat for the treatment of obesity and diabetes.


Energesis Receives Phase II SBIR Award to Continue Development of Approved Drugs

June, 2016 - Energesis' previous work on approved compounds as brown fat recruiters was recognized with a phase II award to continue the company's work toward developing a novel approach to obesity.


Massachusetts Life Sciences Center Grants Energesis a Milestone Achievement Program (MAP) Award

May, 2015 - Energesis was selected as one of the winners of the MLSC's new MAP grant awards. The company will receive $200,000 in funding as one of the 12 awardees. MLSC press release.


Energesis Establishes Research Collaboration with Johnson & Johnson Innovation

June, 2014 - Janssen Pharmaceuticals, Inc. and Johnson & Johnson Innovation have established a collaboration with Energesis, aimed at identifying biological compounds that stimulate the formation of new brown fat for use in treating metabolic diseases. "J&J Innovation shows off its new summer lineup of biotech deals", Fierce Biotech.


Energesis Awarded Phase I SBIR Grant to Investigate Molecular Mechanisms for Creating New Brown Fat

May, 2014 - Energesis has received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health to identify molecular targets capable of recruiting new brown adipocytes. This work is being supported by the National Institute for Diabetes and Digestive and Kidney Disease (NIDDK).

 

Energesis Awarded Phase I SBIR Grant to Investigate Approved Drugs for Creating New Brown Fat

March, 2012 - Energesis has received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health to investigate the use of existing drugs to create new brown fat in patients and identify safe molecular mechanisms of action for expanding brown fat. This work is being supported by the National Institute for Diabetes and Digestive and Kidney Disease (NIDDK).


Energesis Press

Meet Brian Freeman of Energesis Pharmaceuticals, Boston Voyager

The Skinny on the Benefits of Brown Fat, Boston Globe

Energesis and LabCentral Startups Featured in Science Magazine

Treating Fat with Fat, The Scientist

Entrepreneurs and Venture Capitalists – Piercing the "Pall of Gloom" Over Obesity Drugs, Biopharmconsortium

A Proton-Transporting Protein As An Obesity Drug Target, Chemical & Engineering News

Energesis Pharmaceuticals, Co-Founded by Sirtris Vet, Seeks to Tap Power of "Good Fat" in Fighting Obesity and Diabetes, Xconomy